Joseph S Domino1, Jonggyu Baek1, William J Meurer1, Nelda Garcia1, Lewis B Morgenstern1, Morgan Campbell1, Lynda D Lisabeth2. 1. From the Department of Epidemiology (J.S.D., J.B., L.B.M., L.D.L.), University of Michigan School of Public Health; Department of Emergency Medicine (W.J.M.) and Stroke Program (N.G., L.B.M., L.D.L.), University of Michigan Medical School, Ann Arbor; and private practice (M.C.), Corpus Christi, TX. 2. From the Department of Epidemiology (J.S.D., J.B., L.B.M., L.D.L.), University of Michigan School of Public Health; Department of Emergency Medicine (W.J.M.) and Stroke Program (N.G., L.B.M., L.D.L.), University of Michigan Medical School, Ann Arbor; and private practice (M.C.), Corpus Christi, TX. llisabet@umich.edu.
Abstract
OBJECTIVE: To explore temporal trends in tissue plasminogen activator (tPA) administration for acute ischemic stroke (AIS) in a biethnic community without an academic medical center and variation in trends by age, sex, ethnicity, and stroke severity. METHODS: Cases of AIS were identified from 7 hospitals in the Brain Attack Surveillance in Corpus Christi (BASIC) project, a population-based surveillance study between January 1, 2000, and June 30, 2012. tPA, demographics, and stroke severity as assessed by the NIH Stroke Scale (NIHSS) were ascertained from medical records. Temporal trends were explored using generalized estimating equations, and adjustment made for age, sex, ethnicity, and NIHSS. Interaction terms were included to test for effect modification. RESULTS: There were 5,277 AIS cases identified from 4,589 unique individuals. tPA use was steady at 2% and began increasing in 2006, reaching 11% in subsequent years. Stroke severity modified temporal trends (p = 0.003) such that cases in the highest severity quartile (NIHSS > 8) had larger increases in tPA use than those in lower severity quartiles. Although ethnicity did not modify the temporal trend, Mexican Americans (MAs) were less likely to receive tPA than non-Hispanic whites (NHWs) due to emerging ethnic differences in later years. CONCLUSIONS: Dramatic increases in tPA use were apparent in this community without an academic medical center. Primary stroke center certification likely contributed to this rise. Results suggest that increases in tPA use were greater in higher severity patients compared to lower severity patients, and a gap between MAs and NHWs in tPA administration may be emerging.
OBJECTIVE: To explore temporal trends in tissue plasminogen activator (tPA) administration for acute ischemic stroke (AIS) in a biethnic community without an academic medical center and variation in trends by age, sex, ethnicity, and stroke severity. METHODS: Cases of AIS were identified from 7 hospitals in the Brain Attack Surveillance in Corpus Christi (BASIC) project, a population-based surveillance study between January 1, 2000, and June 30, 2012. tPA, demographics, and stroke severity as assessed by the NIH Stroke Scale (NIHSS) were ascertained from medical records. Temporal trends were explored using generalized estimating equations, and adjustment made for age, sex, ethnicity, and NIHSS. Interaction terms were included to test for effect modification. RESULTS: There were 5,277 AIS cases identified from 4,589 unique individuals. tPA use was steady at 2% and began increasing in 2006, reaching 11% in subsequent years. Stroke severity modified temporal trends (p = 0.003) such that cases in the highest severity quartile (NIHSS > 8) had larger increases in tPA use than those in lower severity quartiles. Although ethnicity did not modify the temporal trend, Mexican Americans (MAs) were less likely to receive tPA than non-Hispanic whites (NHWs) due to emerging ethnic differences in later years. CONCLUSIONS: Dramatic increases in tPA use were apparent in this community without an academic medical center. Primary stroke center certification likely contributed to this rise. Results suggest that increases in tPA use were greater in higher severity patients compared to lower severity patients, and a gap between MAs and NHWs in tPA administration may be emerging.
Authors: Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama Journal: Stroke Date: 2011-05-26 Impact factor: 7.914
Authors: Gregg C Fonarow; Mathew J Reeves; Xin Zhao; DaiWai M Olson; Eric E Smith; Jeffrey L Saver; Lee H Schwamm Journal: Circulation Date: 2010-02-08 Impact factor: 29.690
Authors: Paisith Piriyawat; Miriam Smajsová; Melinda A Smith; Sanjay Pallegar; Areej Al-Wabil; Nelda M Garcia; Jan M Risser; Lemuel A Moyé; Lewis B Morgenstern Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Tong Meng; Amber W Trickey; Alex H S Harris; Loretta Matheson; Sarah Rosenthal; Abd Al-Rahman Traboulsi; Jeffrey L Saver; Todd Wagner; Prasanthi Govindarajan Journal: Front Neurol Date: 2022-03-04 Impact factor: 4.003